Medicaid Provider SpendingClaims paid 2018–2024 · HHS public file
Home › TX › Texarkana › NPI 1295736734
Clinic

Christus Health Ark-La-Tex

Christus Health Ark-La-Tex was paid $15.64M by Medicaid between Jan 2018 and Dec 2024, across 237 billing codes. Its largest line is 99284, emergency room visit (serious) — 27% of everything it billed.

33Billing provider infoCHRISTUS HEALTH ARK-LA-TEX
TEXARKANA, TX 75503
33aNPI1295736734assigned 08/09/2005
33bProvider typeAmbulatory Surgical Clinic/Center
28Total paid$15.64M
24GClaims465,458
24DCodes billed237
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers

Next to other Ambulatory Surgical Clinic/Center providers in Texas

Rank by total paid#32 of 320
Median peer was paid$205K
This provider vs. median76×

Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.

Box 24A · Dates of service

Paid by month

$0$250K$500K$750K2018201920202021202220232024
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
YearClaimsPaid
201846,398$663K
201949,257$709K
202043,643$683K
202174,910$2.48M
202290,343$5.12M
202391,376$4.15M
2024incomplete69,531$1.83M
Box 24 · Service lines

What it billed for

CodeServiceShareClaimsBene. recordsPaid
99284 Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity 27% 11,517 10,522 $4.15M
99283 Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity 15% 21,455 20,480 $2.42M
87428 4.8% 11,038 10,383 $746K
99285 Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life 4.6% 2,122 1,946 $712K
99282 Emergency department visit for the evaluation and management, low to moderate severity 3.8% 7,460 7,245 $601K
80053 Comprehensive metabolic panel 3.8% 36,637 29,971 $593K
74177 Computed tomography, abdomen and pelvis; with contrast material 3.5% 3,745 3,416 $542K
97110 Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion 2.8% 6,811 1,523 $437K
93005 Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report 2.6% 16,011 12,886 $411K
70450 Computed tomography, head or brain; without contrast material 2.3% 4,268 3,855 $353K
85025 Blood count; complete (CBC), automated, and automated differential WBC count 2.0% 42,368 33,576 $312K
87633 Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets 2.0% 1,291 1,186 $309K
225 more codes
96365 Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour 1.9% 2,173 $305K
59025 Fetal non-stress test 1.3% 1,559 $208K
71045 Radiologic examination, chest; single view 1.3% 13,652 $207K
72148 Magnetic resonance imaging, lumbar spine; without contrast material 1.0% 762 $157K
G0463 Hospital outpatient clinic visit for assessment and management of a patient <1% 9,193 $145K
87804 Infectious agent antigen detection by immunoassay; Influenza, each type <1% 7,931 $120K
99212 Office or other outpatient visit for the evaluation and management of an established patient, straightforward <1% 885 $111K
77067 Screening mammography, bilateral, including computer-aided detection <1% 1,692 $110K
96413 Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance <1% 794 $108K
71046 Radiologic examination, chest; 2 views <1% 5,682 $93K
72125 Computed tomography, cervical spine; without contrast material <1% 821 $90K
81001 <1% 24,003 $82K
87798 Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism <1% 2,554 $80K
99214 Doctor's office visit, returning patient (more involved) <1% 1,505 $80K
87880 Infectious agent antigen detection by immunoassay; Streptococcus, group A <1% 5,281 $77K
99213 Doctor's office visit, returning patient (routine) <1% 1,334 $75K
84484 <1% 10,011 $74K
41899 Unlisted procedure, dentoalveolar structures <1% 95 $70K
83880 <1% 3,547 $70K
93306 Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete <1% 626 $66K
80048 Basic metabolic panel (calcium, ionized) <1% 6,449 $63K
76805 Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation <1% 948 $61K
71260 Computed tomography, thorax, diagnostic; with contrast material <1% 499 $60K
96366 Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour <1% 716 $54K
86901 <1% 2,419 $50K
J1100 Injection, dexamethasone sodium phosphate, 1 mg <1% 4,225 $47K
87486 <1% 1,290 $46K
87581 <1% 1,290 $46K
36415 Collection of venous blood by venipuncture <1% 12,955 $44K
80307 Drug test(s), presumptive, any number of drug classes; immunoassay <1% 870 $42K
83605 <1% 4,772 $39K
74176 Computed tomography, abdomen and pelvis; without contrast material <1% 641 $39K
J2405 Injection, ondansetron hydrochloride, per 1 mg <1% 11,319 $39K
96361 Intravenous infusion, hydration; each additional hour <1% 1,052 $39K
87420 <1% 2,890 $38K
87086 Culture, bacterial; quantitative colony count, urine <1% 5,453 $38K
83690 <1% 5,591 $34K
81025 <1% 4,528 $33K
20610 <1% 368 $32K
J1642 Injection, heparin sodium, (heparin lock flush), per 10 units <1% 2,815 $31K
87081 <1% 3,912 $31K
94640 Pressurized or nonpressurized inhalation treatment for acute airway obstruction <1% 3,031 $29K
87040 <1% 3,394 $28K
97530 Therapeutic activities, direct patient contact, each 15 minutes <1% 1,366 $27K
87426 Infectious agent antigen detection, SARS-CoV-2 (COVID-19) <1% 781 $26K
80305 <1% 2,168 $26K
77063 Screening digital breast tomosynthesis, bilateral <1% 1,336 $24K
82565 <1% 1,947 $23K
84702 <1% 2,353 $22K
83735 <1% 4,997 $22K
96374 Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance <1% 4,393 $20K
70553 Magnetic resonance imaging, brain; without contrast material, followed by contrast material and further sequences <1% 64 $18K
82962 <1% 7,693 $18K
86850 <1% 1,312 $18K
97161 <1% 345 $18K
J1885 Injection, ketorolac tromethamine, per 15 mg <1% 4,620 $16K
80050 General health panel <1% 359 $15K
Q9967 Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml <1% 4,020 $15K
76705 Ultrasound, abdominal, real time with image documentation; limited <1% 1,000 $15K
96372 Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular <1% 3,010 $14K
J0696 Injection, ceftriaxone sodium, per 250 mg <1% 1,971 $14K
73562 <1% 568 $14K
97162 <1% 322 $13K
85610 <1% 5,572 $13K
87635 Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe <1% 351 $12K
J7030 Infusion, normal saline solution , 1000 cc <1% 3,764 $12K
73030 <1% 738 $12K
84443 Thyroid stimulating hormone (TSH) <1% 2,452 $11K
82077 <1% 929 $11K
72141 <1% 49 $11K
87186 <1% 2,370 $10K
76801 <1% 294 $10K
73110 <1% 601 $9K
78452 Myocardial perfusion imaging, tomographic (SPECT); multiple studies at rest and/or stress <1% 51 $9K
85730 <1% 2,504 $8K
86900 <1% 2,422 $8K
73610 <1% 604 $8K
73630 <1% 408 $8K
85027 <1% 1,839 $8K
96375 Therapeutic injection; each additional sequential IV push <1% 3,763 $7K
A9579 Injection, gadolinium-based magnetic resonance contrast agent, not otherwise specified (nos), per ml <1% 413 $7K
J1650 Injection, enoxaparin sodium, 10 mg <1% 156 $7K
76856 Ultrasound, pelvic (nonobstetric), real time with image documentation; complete <1% 255 $7K
72100 <1% 356 $7K
84703 <1% 925 $7K
80320 <1% 462 $7K
96360 Intravenous infusion, hydration; initial, 31 minutes to 1 hour <1% 31 $7K
73721 Magnetic resonance imaging, any joint of lower extremity; without contrast material <1% 30 $7K
J3490 Unclassified drugs <1% 2,079 $7K
87077 <1% 1,041 $6K
83036 Hemoglobin; glycosylated (A1C) <1% 1,238 $6K
87210 <1% 1,114 $6K
71275 Computed tomographic angiography, chest, with contrast material <1% 32 $6K
U0003 Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r <1% 58 $5K
G0378 Hospital observation service, per hour <1% 1,555 $5K
93975 <1% 84 $5K
73502 <1% 290 $4K
93971 <1% 128 $4K
85379 <1% 533 $4K
76818 <1% 483 $4K
86328 <1% 326 $4K
76819 Fetal biophysical profile; without non-stress testing <1% 268 $4K
73130 <1% 225 $4K
74018 <1% 266 $3K
J1170 Injection, hydromorphone, up to 4 mg <1% 3,319 $3K
82728 <1% 338 $3K
80061 Lipid panel <1% 483 $3K
93017 <1% 80 $3K
71020 <1% 330 $3K
80143 <1% 208 $3K
86140 <1% 612 $3K
95811 <1% 16 $3K
J2270 Injection, morphine sulfate, up to 10 mg <1% 3,480 $2K
87088 <1% 324 $2K
80179 <1% 188 $2K
C1751 Catheter, infusion, inserted peripherally, centrally or midline (other than hemodialysis) <1% 1,458 $2K
76830 Ultrasound, transvaginal <1% 44 $2K
82553 <1% 248 $2K
76815 Ultrasound, pregnant uterus, real time with image documentation, limited <1% 216 $2K
A9500 Technetium tc-99m sestamibi, diagnostic, per study dose <1% 53 $2K
73560 <1% 113 $2K
80329 <1% 159 $2K
94760 <1% 249 $2K
87491 Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe <1% 46 $1K
87591 Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe <1% 46 $1K
J1200 Injection, diphenhydramine hcl, up to 50 mg <1% 2,170 $1K
Q9963 High osmolar contrast material, 350-399 mg/ml iodine concentration, per ml <1% 91 $1K
84466 <1% 174 $1K
J3010 Injection, fentanyl citrate, 0.1 mg <1% 3,026 $1K
97140 Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) <1% 681 $1K
M0243 Intravenous infusion or subcutaneous injection, casirivimab and imdevimab includes infusion or injection, and post administration monitoring <1% 34 $1K
83615 <1% 211 $1K
82607 <1% 214 $1K
U0005 Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 <1% 80 $1K
81003 <1% 622 $1K
76376 <1% 79 $954.30
76642 <1% 33 $948.46
71010 <1% 208 $909.00
71271 <1% 12 $755.12
0202U Oncology (prostate), multianalyte, gene expression profiling <1% 701 $743.16
73565 <1% 55 $725.91
83540 <1% 181 $695.97
87070 <1% 97 $669.38
J7050 Infusion, normal saline solution, 250 cc <1% 2,107 $627.89
J0330 Injection, succinylcholine chloride, up to 20 mg <1% 248 $593.83
87807 <1% 81 $585.45
82947 <1% 92 $582.51
A6453 Self-adherent bandage, elastic, non-knitted/non-woven, width less than three inches, per yard <1% 283 $566.20
J2704 Injection, propofol, 10 mg <1% 1,730 $555.51
J2250 Injection, midazolam hydrochloride, per 1 mg <1% 1,743 $536.53
84132 <1% 245 $503.54
97116 <1% 96 $445.36
85045 <1% 176 $435.05
71250 <1% 13 $430.00
A9270 Non-covered item or service <1% 5,359 $417.74
J2930 Injection, methylprednisolone sodium succinate, up to 125 mg <1% 379 $381.28
J2274 Injection, morphine sulfate, preservative-free for epidural or intrathecal use, 10 mg <1% 90 $371.20
J0690 Injection, cefazolin sodium, 500 mg <1% 1,156 $359.29
85652 <1% 179 $347.29
97166 <1% 15 $343.73
85014 <1% 320 $343.27
86920 <1% 19 $340.00
84100 <1% 98 $306.93
76770 <1% 14 $284.27
J0665 Injection, bupivicaine, not otherwise specified, 0.5 mg <1% 270 $270.43
J1815 Injection, insulin, per 5 units <1% 134 $245.48
87205 <1% 83 $233.45
93356 <1% 98 $213.09
82805 <1% 19 $202.60
85007 <1% 68 $197.30
84295 <1% 82 $188.70
97016 <1% 35 $168.61
C9803 Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source <1% 41 $162.87
73090 <1% 13 $152.00
94729 <1% 12 $144.60
82378 <1% 12 $135.45
94726 <1% 12 $132.66
99281 Emergency department visit for the evaluation and management, self-limited or minor <1% 46 $115.77
93296 <1% 14 $112.82
82150 <1% 20 $111.12
82746 <1% 13 $110.67
80076 <1% 14 $101.88
84439 <1% 12 $77.28
83037 <1% 40 $62.85
99211 Office or other outpatient visit for the evaluation and management of an established patient, minimal severity <1% 355 $59.66
A6402 Gauze, non-impregnated, sterile, pad size 16 sq. in. or less, without adhesive border, each dressing <1% 70 $55.62
J2360 Injection, orphenadrine citrate, up to 60 mg <1% 30 $49.59
A6257 Transparent film, sterile, 16 sq. in. or less, each dressing <1% 48 $48.89
J2765 Injection, metoclopramide hcl, up to 10 mg <1% 147 $47.65
A6258 Transparent film, sterile, more than 16 sq. in. but less than or equal to 48 sq. in., each dressing <1% 12 $43.81
96376 <1% 431 $40.87
J0780 Injection, prochlorperazine, up to 10 mg <1% 38 $40.32
J2785 Injection, regadenoson, 0.1 mg <1% 32 $37.07
J2550 Injection, promethazine hcl, up to 50 mg <1% 149 $36.37
J1644 Injection, heparin sodium, per 1000 units <1% 189 $35.03
J2060 Injection, lorazepam, 2 mg <1% 64 $32.48
99291 Critical care, evaluation and management of the critically ill patient, first 30-74 minutes <1% 17 $24.48
J2175 Injection, meperidine hydrochloride, per 100 mg <1% 17 $15.33
J3475 Injection, magnesium sulfate, per 500 mg <1% 15 $15.28
J2919 Injection, methylprednisolone sodium succinate, 5 mg <1% 45 $5.34
J1596 Injection, glycopyrrolate, 0.1 mg <1% 223 $3.71
G1010 Clinical decision support mechanism stanson, as defined by the medicare appropriate use criteria program <1% 216 $0.26
G1004 Clinical decision support mechanism national decision support company, as defined by the medicare appropriate use criteria program 0% 283 $0.00
J7120 Ringers lactate infusion, up to 1000 cc 0% 229 $0.00
C1713 Anchor/screw for opposing bone-to-bone or soft tissue-to-bone (implantable) 0% 30 $0.00
99215 Doctor's office visit, returning patient (complex) 0% 13 $0.00
J7040 Infusion, normal saline solution, sterile (500 ml = 1 unit) 0% 36 $0.00
99152 0% 13 $0.00
C9113 Injection, pantoprazole sodium, per vial 0% 13 $0.00
C1894 Introducer/sheath, other than guiding, other than intracardiac electrophysiological, non-laser 0% 12 $0.00
A4216 Sterile water, saline and/or dextrose, diluent/flush, 10 ml 0% 103 $0.00
90662 0% 15 $0.00
Q9969 Tc-99m from non-highly enriched uranium source, full cost recovery add-on, per study dose 0% 63 $0.00
C1769 Guide wire 0% 111 $0.00
J1010 Injection, methylprednisolone acetate, 1 mg 0% 39 $0.00
J2003 Injection, lidocaine hydrochloride, 1 mg 0% 19 $0.00
J1030 Injection, methylprednisolone acetate, 40 mg 0% 15 $0.00
J2001 Injection, lidocaine hcl for intravenous infusion, 10 mg 0% 68 $0.00
86769 0% 39 $0.00
G0008 Administration of influenza virus vaccine 0% 50 $0.00
J1040 Injection, methylprednisolone acetate, 80 mg 0% 17 $0.00
J2371 Injection, phenylephrine hydrochloride, 20 micrograms 0% 22 $0.00
A6450 Light compression bandage, elastic, knitted/woven, width greater than or equal to five inches, per yard 0% 14 $0.00
97014 0% 47 $0.00
J1940 Injection, furosemide, up to 20 mg 0% 15 $0.00

Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.

From NPPES

Who's on the registration

Authorized officialADAMS, JASON (PRESIDENT)
Same official

Other billing entities under ADAMS, JASON

Full network →
ProviderLocationPaid
Urgent Care Specialists PCWilbraham, MA$1.33M
Urgent Care Specialists PCHolden, MA$367K
Christus Health Ark-La-TexTexarkana, TX$306K
Adams Plastic Surgery, PCFarmington, NM$134K
Christus Health Ark-La-TexTexarkana, TX$91K
Christus Health Ark-La-TexTexarkana, TX$37K
Urgent Care Specialists PCHolden, MA$8K
Christus Health Ark-La-TexTexarkana, TX$2K

Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.